• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 14B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 14B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC14
Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Chest Pain (1776); Dysphagia/ Odynophagia (1815); Vomiting (2144); Weight Changes (2607)
Event Date 10/07/2021
Event Type  Injury  
Event Description
It was reported that a linx device was explanted due to dysphagia, non-cardiac chest pain, regurgitation, weight loss, and coughing.
 
Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.No lot number was provided therefore a device history could not be done.Additional information was requested, and the following was obtained: prior to linx placement, did the patient have an egd, ph, and manometry studies done? if yes, could you please share the results? 3/4/21 ph: composite demeester score normal at 3.1 in proximal sensor but demonstrates numerous episodes of reflux throughout the day from 6am-9pm; aet 5.2% 3/4/21 manometry: normal les relaxation with median irp 0.6 and fragmented peristalsis with dci 677.0 mmhg-cm-s, mean wave amplitude 44.9 mmhg 1/21/21 egd: 2cm hiatal hernia, la grade a esophagitis, gastric polyp, gastritis; pathology negative for intestinal metaplasia; positive for active esophagitis.What is the lot number of the linx device? - n/a.When using the linx sizing device what technique was used to determine the size? n/a.Did the patient have an autoimmune disease? n/a.Is the patient currently taking steroids / immunization drugs? not at this time but she did try prednisone prior to explant.Did the patient have any pre-existing dysphagia or other conditions (other than gerd)? n/a.How severe was the dysphagia/odynophagia before intervention? pretty severe given weight loss of 20+ lbs.Were there any intra-operative complications during implant? n/a.Was there any hiatal or crural repair done at the same time as the implant? n/a.Were there any other contributing factors that led to the removal of the device other than the reported dysphagia, non-cardiac chest pain, regurgitation, weight loss, and coughing? n/a.Besides the reported dysphagia non-cardiac chest pain, regurgitation, weight loss, and coughing., what was the reason for removal of the linx device? n/a.Was the device found in the correct position/geometry at the time of removal? per egd 9/20/21 linx device impression in appropriate location.
 
Manufacturer Narrative
(b)(4).Date sent: 11/30/2021.Investigation summary: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.No further investigation will be conducted on this complaint as the device is found to meet the specifications.Overall, no analysis conclusions relevant to the patient experience were found.
 
Manufacturer Narrative
(b)(4).Date sent: 11/18/2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 14B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview 55126
6107428552
MDR Report Key12711625
MDR Text Key282516449
Report Number3008766073-2021-00220
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005349
UDI-Public00855106005349
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 11/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberLXMC14
Device Catalogue NumberLXMC14
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/02/2021
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/14/2021
Initial Date FDA Received10/28/2021
Supplement Dates Manufacturer Received11/02/2021
11/29/2021
Supplement Dates FDA Received11/19/2021
11/30/2021
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-